NYSEARCA:XBI

SPDR S&P Biotech ETF - XBI Stock Forecast, Price & News

$79.32

+0.46 (+0.58%)

(As of 09/30/2022 12:00 AM ET)

Add

Today's Range: $78.65
▼
$82.15
50-Day Range: $75.06
▼
$94.90
52-Week Range: $61.78
▼
$134.79

Volume: 13.49 million shs
Average Volume: 13.54 million shs
Market Capitalization: $7.41 billion

P/E Ratio: N/A
Dividend Yield: 0.00%
Price Target: N/A

Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

30 days | 90 days | 365 days | Advanced Chart

Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer SSgA

Fund NameSPDR S&P Biotech ETF

Tax ClassificationRegulated Investment Company

SymbolNYSEARCA:XBI

Inception Date1/31/2006

Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio

Webwww.spdrs.com

Phone+1-866-7872257

Fund Focus

Asset ClassEquity

BenchmarkS&P Biotech Index

CategorySector

FocusHealth Care

Development LevelDeveloped Markets

RegionNorth America

Fund Statistics

Assets Under Management$6.84 billion

Average Daily Volume$11.97 million

Discount/Premium-0.04%

ETF Expenses

Management Fee0.35%

Other Expenses0.00%

Total Expenses0.35%

Fee Waiver0.00%

Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSgA Funds Management, Inc.

AdvisorSSgA Funds Management, Inc.

CustodianState Street Bank and Trust Company

DistributorState Street Global Advisors Funds Distributors, LLC

Transfer AgentState Street Bank and Trust Company

Trustee

Lead Market MakerVirtu Financial

Geographic Exposure of XBI

Currency Exposure of XBI

Sector Exposure of XBI

Industry Exposure of XBI

Key Executives

James E. Ross (Age 52)
President, Trustee

Peter A. Ambrosini (Age 69)
Chief Compliance Officer

Michael P. Riley (Age 44)
Vice President

Gary L. French (Age 64)
Treasurer

John W. Clark (Age 46)
Assistant Treasurer

Matthew W. Flaherty (Age 42)
Assistant Treasurer

Chad C. Hallett (Age 47)
Assistant Treasurer of Street tracks series trust

Mary Moran Zeven (Age 52)
Secretary

Scott M. Zoltowski (Age 44)
Assistant Secretary

Dave Kelly
Independent Trustee

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

XBI Stock - Frequently Asked Questions

How have XBI shares performed in 2022?: SPDR S&P Biotech ETF's stock was trading at $111.96 on January 1st, 2022. Since then, XBI stock has decreased by 29.2% and is now trading at $79.32.
View the best growth stocks for 2022 here.
What other stocks do shareholders of SPDR S&P Biotech ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Biotechnology ETF (IBB), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

What is SPDR S&P Biotech ETF's stock symbol?: SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."
How do I buy shares of SPDR S&P Biotech ETF?: Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is SPDR S&P Biotech ETF's stock price today?: One share of XBI stock can currently be purchased for approximately $79.32.
How much money does SPDR S&P Biotech ETF make?: SPDR S&P Biotech ETF (NYSEARCA:XBI) has a market capitalization of $7.41 billion.
How can I contact SPDR S&P Biotech ETF?: SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The official website for the company is www.spdrs.com. The exchange traded fund can be reached via phone at +1-866-7872257.

This page (NYSEARCA:XBI) was last updated on 10/1/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms